ALT

AU000000ALT0

Medical Equipment, Supplies & Distribution

Delayed Australian S.E. Other stock markets 11:32:57 2023-02-27 pm EST			5-day change	1st Jan Change
0.001 ^AUD	-.--%		-.--%	-.--%

2023	Analytica Appoints Voluntary Administrators	MT
2023	Analytica CEO Resigns	MT

Rights Issue: 1 new share @ 0.024 AUD for 15 existing shares

April 28, 2014

MarketScreener.com By

Latest news about ANALYTICA

Analytica Appoints Voluntary Administrators	23-06-12	MT
Analytica CEO Resigns	23-05-12	MT
Dr Michael Monsour Will Take on the Role of Executive Chairman of Analytica Limited	23-05-11	CI
Analytica Limited Announces Resignation of Geoff Daly as CEO	23-05-11	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-31	CI
Analytica Limited Auditor Raises 'Going Concern' Doubt	22-08-30	CI
Analytica Secures Canadian Patent for Pelvic Floor Exercise System	22-07-13	MT
Analytica Secures European, Indian Patent for Training Device	22-05-18	MT
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-22	CI
Analytica Secures US Patent for PeriCoach Device	21-11-10	MT
Analytica Limited Auditor Raises 'Going Concern' Doubt	21-09-29	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-31	CI
Analytica : Secures US Patent for Pelvic Floor Exercise System	21-04-30	MT
Analytica Announces Expansion of Enhanced Infusion System into Middle East	21-04-27	CI
Analytica : Plans Up to $3 Million Share Placement	21-04-23	MT
Analytica : Enters Deal to Distribute Intravenous Flow Monitoring Device in Middle East	21-04-20	MT
Analytica Limited Enters into Joint Venture Agreement to Manufacture, Distribute and Market the System in China, Macau, Hong Kong and Taiwan	21-03-31	CI
Analytica Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-02-26	CI
Analytica Ltd Announces Publication of an Independent Clinical Trial from the University of New Mexico in the Journal of Female Pelvic Medicine & Reconstructive Surgery, the Official Journal of the American Urogynecologic Society, Demonstrating PeriCoach Non-Inferiority to In- Clinic Pelvic Floor Physical Therapy	20-11-19	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-08-30	CI
Analytica Ltd Announces Resignation of Thomas Lönngren, Non-Executive Director	20-08-17	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2019	20-02-26	CI
Analytica Ltd Announces Middle East Distribution Agreement Supplementary Disclosure	19-12-12	CI
Analytica Ltd. Reports Earnings Results for the Full Year Ended June 30, 2019	19-08-22	CI

Analytica Ltd is an Australia-based company. The Company is engaged in the design, development, and supply of medical devices. Its products include PeriCoach System, an e-health treatment system for women who suffer stress urinary incontinence (SUI), pelvic organ prolapse (PUP), and other conditions. It has Australia regulatory clearance in Australia, CE mark and FDA 510(k) clearance.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ANALYTICA	-.--%	3.12M
ABBOTT LABORATORIES	-5.35%	181B
MEDTRONIC PLC	-5.23%	100B
BECTON, DICKINSON AND COMPANY	-7.75%	65.01B
HOYA CORPORATION	+16.68%	45.75B
DEXCOM, INC.	-9.21%	44.8B
CENCORA, INC.	+8.09%	43.72B
METTLER-TOLEDO INTERNATIONAL, INC.	+11.97%	29.01B
TERUMO CORPORATION	+18.69%	26.03B
WEST PHARMACEUTICAL SERVICES, INC.	-5.34%	24.28B